What's New

Front Page

AFTD quality of life grant update image

Help & Support: AFTD Quality of Life Grants Now Provide Better Benefits to People with FTD

AFTD’s Comstock Grant program, which offers modest financial assistance to people with FTD and their care partners, has…

Read More >
culturally diverse peoples delay in bvFTD study image

People with Non-English First Language Have Delayed bvFTD Symptom Onset, Study Shows

Researchers at the University of Sydney discovered that Australians born overseas who spoke a first language other…

Read More >
woman shares tumultuous FTD journey image

“I Vowed to Take Care of Him; Then He Filed for Divorce” – Article Shares Woman’s Tumultuous FTD Journey

In a recent article published on the website The Cut, author Katherine Nichols shares the tumultuous FTD…

Read More >
alyssa nash discusses genetic FTD status image

Iowa Woman Discusses Her Genetic FTD Status in Fox News Interview

Alyssa Nash, a 27-year-old hospital receptionist, shared her experiences on the FTD journey and learning she carries…

Read More >
dr. chiadi onyike named AFTD medical adviory council chair elect image

Dr. Chiadi Onyike Named AFTD Medical Advisory Council Chair-Elect

During their annual meeting at the 2023 Education Conference, AFTD’s Board of Directors named Chiadi Onyike, MD,…

Read More >
the LGBTQIA+ perspective on the FTD journey image

Guest Feature: “That Thin Thread Blooms into A Rainbow” – The FTD Journey from the LGBTQIA+ Perspective

The FTD journey is wrought with hardships, with families often facing a lengthy diagnostic process, steep costs…

Read More >
tips and advice documenting changing behaviors image

Tips & Advice: Documenting Changing Behavior

Many behaviors caused by FTD, such as aggression, disinhibition, delusions, and apathy, are challenging and distressing for…

Read More >

Advancing Hope: Accelerating Drug Discovery for FTD – New Awards From a Long-Standing Partnership

Before FTD researchers can initiate a clinical trial of a new medication, they must carry out preclinical…

Read More >

Wave Life Sciences Ends FTD/ALS Trial of WVE-004

Yesterday, Wave Life Sciences announced that it ended its FOCUS-C9 clinical trial for the drug WVE-004, which…

Read More >
major leaders in FTD and ALS convene for C9orf72 summit image

Advancing Hope: Major Leaders in FTD and ALS Research Gather in Arizona for Summit on C9orf72 Gene

In March, prominent leaders in FTD and ALS research gathered in Scottsdale, Arizona, for the first-ever summit…

Read More >